ConductScience.org, home

Paper2124138

Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.

Whitford P and 3 others. Br J Cancer, 1990. Cited by 84 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Papers, record 2124138. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2124138

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.
PubMed
Journal
Br J Cancer
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
84
iCite
Relative citation ratio, by iCite
1.93
iCite
Revised in PubMed
2019-05-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Whitford PP
2Mallon EAE A
3George WDW D
4Campbell AMA M

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Lymphocytes, Tumor-InfiltratingMajor topic
Antigens, Differentiation, T-Lymphocyte
CD4 Antigens
CD8 Antigens
Female
Flow Cytometry
HLA-DR Antigens
Humans

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12954917Immunohistological analysis of lymphocyte subpopulations infiltrating breast carcinomas and benign lesions.Int J Cancer1987https://conductscience.org/library/papers/2954917PubMed
26268135Lymphocytes infiltrating human breast cancers lack K-cell activity and show low levels of NK-cell activity.Br J Cancer1981https://conductscience.org/library/papers/6268135PubMed
36976792Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.Br J Cancer1981https://conductscience.org/library/papers/6976792PubMed
42783889Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2783889PubMed
53032398Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast.Cancer1987https://conductscience.org/library/papers/3032398PubMed
63257161Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity.Cancer Res1988https://conductscience.org/library/papers/3257161PubMed
72679456Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.Ann Surg1989https://conductscience.org/library/papers/2679456PubMed
82578284Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies.Br J Cancer1985https://conductscience.org/library/papers/2578284PubMed
96193308Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.J Natl Cancer Inst1983https://conductscience.org/library/papers/6193308PubMed
103031660Interleukin 2 binding molecule distinct from the Tac protein: analysis of its role in formation of high-affinity receptors.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3031660PubMed
113086239Separation, phenotyping and limiting dilution analysis of T-lymphocytes infiltrating human solid tumors.Int J Cancer1986https://conductscience.org/library/papers/3086239PubMed
126365132Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.Br J Cancer1984https://conductscience.org/library/papers/6365132PubMed
133315186Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.Cancer Res1987https://conductscience.org/library/papers/3315186PubMed
142688708The interleukin 2 receptor.Annu Rev Cell Biol1989https://conductscience.org/library/papers/2688708PubMed
153264384Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.N Engl J Med1988https://conductscience.org/library/papers/3264384PubMed
162972629Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression.Int J Cancer1988https://conductscience.org/library/papers/2972629PubMed
176365133Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.Br J Cancer1984https://conductscience.org/library/papers/6365133PubMed
182989190Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies.Int J Cancer1985https://conductscience.org/library/papers/2989190PubMed
193099289Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/3099289PubMed
213435700Immunophenotype of the lymphoid cell infiltrates in breast carcinomas of low oestrogen receptor content.Br J Cancer1987https://conductscience.org/library/papers/3435700PubMed

See all 31 referencesDownload CSV of references

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
40593750Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy.Nat Commun2025https://conductscience.org/library/papers/40593750PubMed
36010863Identification of Immune Cell Components in Breast Tissues by a Multiparametric Flow Cytometry Approach.Cancers (Basel)2022https://conductscience.org/library/papers/36010863PubMed
35577913Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression.Sci Rep2022https://conductscience.org/library/papers/35577913PubMed
35437570The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.Cancer Epidemiol Biomarkers Prev2022https://conductscience.org/library/papers/35437570PubMed
33704737Immunotyping and Quantification of Melanoma Tumor-Infiltrating Lymphocytes.Methods Mol Biol2021https://conductscience.org/library/papers/33704737PubMed
33587338Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies.EMBO Mol Med2021https://conductscience.org/library/papers/33587338PubMed
31408436Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.JCI Insight2019https://conductscience.org/library/papers/31408436PubMed
28121628Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer.Oncotarget2017https://conductscience.org/library/papers/28121628PubMed
27473163Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer.J Transl Med2016https://conductscience.org/library/papers/27473163PubMed
23336253The crosstalk: Tumor-infiltrating lymphocytes rich in regulatory T cells suppressed cancer-associated fibroblasts.Acta Oncol2013https://conductscience.org/library/papers/23336253PubMed
23071686CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.PLoS One2012https://conductscience.org/library/papers/23071686PubMed
22420471CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.Breast Cancer Res2012https://conductscience.org/library/papers/22420471PubMed
21666707Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent.Cell Mol Immunol2011https://conductscience.org/library/papers/21666707PubMed
15999153Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma.Pathol Oncol Res2005https://conductscience.org/library/papers/15999153PubMed
11742495EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions.Br J Cancer2001https://conductscience.org/library/papers/11742495PubMed
11250688Gene therapy for carcinoma of the breast: Genetic immunotherapy.Breast Cancer Res2000https://conductscience.org/library/papers/11250688PubMed
10606960
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Clin Exp Immunol2000https://conductscience.org/library/papers/10606960PubMed
9192989High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours.Br J Cancer1997https://conductscience.org/library/papers/9192989PubMed
8855979Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4.Br J Cancer1996https://conductscience.org/library/papers/8855979PubMed
8646519In situ cytokine production by breast cancer tumor-infiltrating lymphocytes.Ann Surg Oncol1996https://conductscience.org/library/papers/8646519PubMed

See all 23 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene
IL2RB3560PubTator's text mininghttps://conductscience.org/library/genes/3560NCBI Gene
TFRC7037PubTator's text mininghttps://conductscience.org/library/genes/7037NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2124138

GET https://conductscience.org/api/papers/v1/2124138/references?page=2